Erythromycin

Generic Name: Erythromycin

Brand Names: Aktipak, Apo-Erythro-S, Benzamycin, E.E.S., Ery, Ery-tab, Erygel, Eryped, Erythro, Erythrocin, Erythrocin Stearate

Drug Type: Small Molecule

Chemical Formula: C_₃₇H_₆₇NO_₁₃

CAS Number: 114-07-8

Unique Ingredient Identifier: 63937KV33D

Background: Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of Azithromycin, Clarithromycin, Spiramycin and others. It was originally discovered in 1952. Erythromycin is widely used for treating a variety of infections,...

Indication: Erythromycin is indicated in the treatment of infections caused by susceptible strains of various bacteria. The indications for erythromycin have been summarized by body system below:

Respiratory infections
...

Associated Conditions: Acne, Acne Vulgaris, Acute Otitis Media caused by Haemophilus Influenzae, Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection, Bacterial Infections, Chancroid, Chlamydia Trachomatis, Chlamydial ophthalmia neonatorum, Community Acquired Pneumonia (CAP), Diphtheria, Erythrasma, Gastroparesis, Granuloma Inguinale, Intestinal amebiasis caused by entamoeba histolytica, Legionella Pneumophila Infections, Listeria infection, Lower Respiratory Tract Infection (LRTI), Lymphogranuloma Venereum, Nongonococcal urethritis, Ophthalmia neonatorum (gonococcal), Pertussis, Postoperative Infections, Primary Syphilis, Respiratory Tract Infections (RTI), Skin and skin structure infections, Staphylococcal Skin Infections, Syphilis, Upper Respiratory Tract Infection, Ureaplasma urethritis, Whooping Cough, Inflammatory papular lesions, Mild Acne vulgaris, Moderate Acne vulgaris, Predominant skin comedones, papules and pustules, Prophylaxis of Rheumatic fever, Pustular lesions, Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes, Superficial ocular infections

Associated Therapies: -

Clinical Trials

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

Phase 3

Terminated

Conditions: Preterm Premature Rupture of Membranes (PPROM)

Interventions: Drug: Azithromycin
Drug: Erythromycin
Drug: Ampicillin
Drug: Amoxicillin

First Posted Date: 2017-02-23

Last Posted Date: 2024-06-25

Lead Sponsor: The University of Texas Medical Branch, Galveston

Target Recruit Count: 21

Registration Number: NCT03060473

Locations: 🇺🇸
St. David's North Austin Medical Center, Austin, Texas, United States
🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

The Effect of Motilin on the Frequency and Amount of Food Intake

Phase 4

Conditions: Healthy
Obesity

Interventions: Drug: Saline
Drug: Erythromycin

First Posted Date: 2017-01-19

Last Posted Date: 2024-07-10

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 15

Registration Number: NCT03024879

Transplacental Transfer of Drugs Used in Pregnant Women

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: paracetamol
Drug: Erythromycin
Drug: Azithromycin

First Posted Date: 2015-12-07

Last Posted Date: 2017-05-03

Lead Sponsor: University Hospital, Gasthuisberg

Target Recruit Count: 250

Registration Number: NCT02622802

Locations: 🇧🇪
University Hospital Gasthuisberg, Leuven, Belgium

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

Not Applicable

Completed

Conditions: Cirrhosis

Interventions: Other: Placebo
Drug: Metaclopramide
Drug: Erythromycin

First Posted Date: 2015-08-19

Last Posted Date: 2017-11-21

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 83

Registration Number: NCT02528760

Locations: 🇮🇳
Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

Not Applicable

Completed

Conditions: Colorectal Cancer Screening

Interventions: Device: PillCam® COLON 2 procedure-CONTROL
Drug: Senna tablets
Drug: PEG
Drug: Metoclopramide
Drug: Erythromycin
Drug: SUPREP oral sulfate solution
Drug: Bisacodyl
Drug: SUPREP oral sulfate solution with Gastrografin

First Posted Date: 2015-06-25

Last Posted Date: 2017-03-07

Lead Sponsor: Medtronic - MITG

Target Recruit Count: 122

Registration Number: NCT02481219

Locations: 🇺🇸
Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States
🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States
🇺🇸
Pinnacle Research Group, LLC, Anniston, Alabama, United States

and more 3 locations

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Phase 1

Completed

Conditions: B-Cell Chronic Lymphocytic Leukemia

Interventions: Drug: Ibrutinib
Drug: Erythromycin
Drug: Voriconazole

First Posted Date: 2015-03-06

Last Posted Date: 2017-06-26

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 26

Registration Number: NCT02381080

Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia

Not Applicable

Conditions: Pneumonia

Interventions: Drug: Xiyanping injection
Drug: wind-heat formula granules
Drug: phlegm-heat formula granules
Drug: second generation cephalosporin
Drug: Fu-xiong San
Drug: Erythromycin
Drug: Azithromycin

First Posted Date: 2015-02-13

Last Posted Date: 2015-02-13

Lead Sponsor: Liaoning University of Traditional Chinese Medicine

Target Recruit Count: 1500

Registration Number: NCT02362906

Locations: 🇨🇳
Affiliated Children's Hospital of Capital University of Medical Sciences, Beijing, Beijing, China
🇨🇳
Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
🇨🇳
Affiliated Hospital of Changchun University of TCM, Changchun, Jilin, China

and more 7 locations